What is the status of the proposed scaling of your nanoneedle diagnostic assay technology? Have any outside researchers validated your findings relating to identified ME/CFS biomarkers using your assay technology?
* Seems I had ME on the brain when I was thinking of questions, the making them covid-19 related completely escaped me at the time.
* regarding the IDO trap hypothesis:
- were more patients tested for matching mutations? are we still in 100%?
- you have previously discussed a test to be performed, one that required a sensitive spectrometer you were waiting for. Was this test conducted? what are the results?